Skip to content

CVRx, Inc. CVRX Free cash flow

Free cash flow at other companies

Abbott logo
AbbottABT
$916M-1.8%
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$6.02M+20.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$28.27M-12.5%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$3.12M+121%

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Calculated from CVRx, Inc.’s reported figures.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s free cash flow?
CVRx, Inc. (CVRX) reported free cash flow of -$12.29M in Q1 2026.
How has CVRx, Inc.'s free cash flow changed year-over-year?
CVRx, Inc.'s free cash flow increased by 4.6% year-over-year, from -$12.88M to -$12.29M.
What is the long-term trend for CVRx, Inc.'s free cash flow?
Over 4 years (2021 to 2025), CVRx, Inc.'s free cash flow has grown at a 9.0% compound annual growth rate (CAGR), from -$28.92M to -$40.75M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.